Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 21, 2024
Early Mortality After Curative-intent Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer-A Population-based Cohort StudyK H Jensen, G Persson, M Pøhl, et al.
Clinical and Translational Radiation Oncology|January 1, 2021
Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trialChristina M Lutz, Marianne M Knap, Lone Hoffmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 2, 2023
Repeated deep-inspiration breath-hold CT scans at planning underestimate the actual motion between breath-holds at treatment for lung cancer and lymphoma patientsLone Hoffmann, M L Ehmsen, J Hansen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2023
Does coronary artery calcium score have an impact on overall survival for locally advanced non-small cell lung cancer treated with definitive radiotherapyAgon Olloni, Carsten Brink, Ebbe L Lorenzen, et al.
Nature Communications|June 23, 2019
Site-selectively generated photon emitters in monolayer MoS<sub>2</sub> via local helium ion irradiationJ Klein, M Lorke, M Florian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2025
Design and pre-trial dose planning quality assurance of the Nordic trial of inhomogeneous dose escalated radiotherapy for patients with limited disease small cell lung cancer: NIELSSara Linde, Ditte S Møller, Mai-Britt Linaa, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 2, 2026
Multicenter Study of Dose Accumulation for Reirradiation: Intercenter Variation in Radiobiological Dose Scaling Introduces Clinically Relevant DifferencesI Wahlstedt, A Appelt, R L Christiansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2025
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 TrialTine Schytte, Marianne M Knap, Charlotte Kristiansen, et al.
Pageof 5